Detailed information for compound 515782

Basic information

Technical information
  • Name: Unnamed compound
  • MW: 344.267 | Formula: C10H17N8O4P
  • H donors: 5 H acceptors: 6 LogP: -2.99 Rotable bonds: 6
    Rule of 5 violations (Lipinski): 1
  • SMILES: C[C@H](Cn1cnc2c1c(N=C(N)N)nc(n2)N)OCP(=O)(O)O
  • InChi: 1S/C10H17N8O4P/c1-5(22-4-23(19,20)21)2-18-3-14-7-6(18)8(15-9(11)12)17-10(13)16-7/h3,5H,2,4H2,1H3,(H2,19,20,21)(H6,11,12,13,15,16,17)/t5-/m1/s1
  • InChiKey: NVIJYRUKLZLSNP-RXMQYKEDSA-N  

Network

Hover on a compound node to display the structore

Synonyms

No synonyms found for this compound

Targets

Known targets for this compound

No curated genes were found associated with this compound

Predicted pathogen targets for this compound

By orthology
No druggable targets predicted by orthology data
By sequence similarity to non orthologous known druggable targets
No druggable targets predicted by sequence similarity

Obtained from network model

Ranking Plot


Putative Targets List


Species Potential target Raw Global Species
Mycobacterium leprae PROBABLE ACETOLACTATE SYNTHASE (LARGE SUBUNIT) ILVB (ACETOHYDROXY-ACID SYNTHASE) 0.0492 0.509 1
Leishmania major putative pyruvate/indole-pyruvate carboxylase, putative 0.0282 0.2722 1
Mycobacterium ulcerans hypothetical protein 0.0492 0.509 1
Entamoeba histolytica fructose-1,6-bisphosphate aldolase, putative 0.0685 0.7263 1
Giardia lamblia Fructose-bisphosphate aldolase 0.0685 0.7263 1
Schistosoma mansoni hypothetical protein 0.0055 0.0175 0.0408
Mycobacterium ulcerans acetolactate synthase large subunit IlvB 0.0282 0.2722 0.4994
Mycobacterium leprae Probable fructose bisphosphate aldolase Fba 0.0335 0.332 0.6111
Plasmodium falciparum acyl-CoA synthetase 0.0282 0.2722 0.5
Mycobacterium tuberculosis Probable acetolactate synthase IlvG (acetohydroxy-acid synthase)(ALS) 0.0492 0.509 1
Schistosoma mansoni acetolactate synthase 0.042 0.4285 1
Loa Loa (eye worm) thiamine pyrophosphate enzyme 0.0282 0.2727 0.9385
Trichomonas vaginalis fructose-bisphosphate aldolase, putative 0.0685 0.7263 1
Mycobacterium ulcerans pyruvate or indole-3-pyruvate decarboxylase Pdc 0.0282 0.2722 0.4994
Schistosoma mansoni survival motor neuron protein 0.0055 0.0175 0.0408
Brugia malayi Thiamine pyrophosphate enzyme, central domain containing protein 0.0492 0.509 1
Echinococcus granulosus survival motor neuron protein 1 0.0271 0.26 1
Trypanosoma cruzi phosphonopyruvate decarboxylase, putative 0.0159 0.1343 0.5
Trichomonas vaginalis fructose-bisphosphate aldolase, putative 0.0685 0.7263 1
Schistosoma mansoni acetolactate synthase 0.042 0.4285 1
Mycobacterium ulcerans hypothetical protein 0.0159 0.1343 0.208
Loa Loa (eye worm) hypothetical protein 0.0271 0.26 0.8947
Trypanosoma brucei phosphonopyruvate decarboxylase-like protein, putative 0.0159 0.1343 0.5
Mycobacterium ulcerans acetolactate synthase 1 catalytic subunit 0.0492 0.509 1
Echinococcus multilocularis survival motor neuron protein 1 0.0271 0.26 0.26
Entamoeba histolytica fructose-1,6-bisphosphate aldolase, putative 0.0685 0.7263 1
Onchocerca volvulus 0.0055 0.0175 1
Trypanosoma cruzi phosphonopyruvate decarboxylase, putative 0.0159 0.1343 0.5
Mycobacterium ulcerans 2-succinyl-5-enolpyruvyl-6-hydroxy-3-cyclohexene-1-carboxylate synthase 0.0087 0.0537 0.0378
Trichomonas vaginalis fructose-bisphosphate aldolase, putative 0.0685 0.7263 1
Mycobacterium ulcerans acetolactate synthase 0.0282 0.2722 0.4994
Mycobacterium tuberculosis Probable oxalyl-CoA decarboxylase OxcA 0.0492 0.509 1
Brugia malayi Iron-sulfur cluster assembly accessory protein 0.0055 0.0175 0.0343
Mycobacterium ulcerans fructose-bisphosphate aldolase 0.0335 0.332 0.6258
Trichomonas vaginalis fructose-bisphosphate aldolase, putative 0.0685 0.7263 1
Trichomonas vaginalis fructose-bisphosphate aldolase, putative 0.0685 0.7263 1
Mycobacterium leprae Probable Acetolactate synthase IlvG (Acetohydroxy-acid synthase)(ALS) 0.0492 0.509 1
Plasmodium vivax acyl-CoA synthetase, putative 0.0282 0.2722 0.5
Trichomonas vaginalis fructose-bisphosphate aldolase, putative 0.0685 0.7263 1
Trypanosoma brucei phosphonopyruvate decarboxylase-like protein, putative 0.0159 0.1343 0.5
Mycobacterium tuberculosis Acetolactate synthase (large subunit) IlvB1 (acetohydroxy-acid synthase) 0.021 0.1922 0.3304
Trichomonas vaginalis fructose-bisphosphate aldolase, putative 0.0685 0.7263 1
Trichomonas vaginalis fructose-bisphosphate aldolase, putative 0.0685 0.7263 1
Treponema pallidum fructose-bisphosphate aldolase 0.0685 0.7263 1
Mycobacterium ulcerans putative oxalyl-CoA decarboxylase 0.0492 0.509 1
Mycobacterium tuberculosis Probable fructose-bisphosphate aldolase Fba 0.0335 0.332 0.6258
Brugia malayi hypothetical protein 0.0271 0.26 0.5108
Loa Loa (eye worm) ILVBL protein 0.0298 0.2906 1

Activities

Activity type Activity value Assay description Source Reference
Activity (functional) 0 Increase in IFNgamma stimulated nitric oxide production in C57BL/6 mouse peritoneal macrophages at 100 uM after 24 hrs ChEMBL. 17964173
Activity (ADMET) 0 Cytotoxicity against mouse L929 cells ChEMBL. 17964173
Activity (ADMET) 0 Cytotoxicity against mouse L1210 cells ChEMBL. 17964173
Activity (ADMET) 0 Cytotoxicity against human HeLaS3 cells ChEMBL. 17964173
Activity (functional) 0 Antiviral activity against MSV ChEMBL. 17964173
Activity (functional) 0 Antiviral activity against HIV1 ChEMBL. 17964173
Activity (functional) 0 Antiviral activity against HIV2 ChEMBL. 17964173

Phenotypes

Whole-cell/tissue/organism interactions

We have no records of whole-cell/tissue assays done with this compound What does this mean?

Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.

Annotated phenotypes:

We have no manually annotated phenotypes for this drug. What does this mean? / Care to help?
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
 
In any case, if you have information about papers containing relevant validation data for this target, please log in using your TDR Targets username and password and send them to us using the corresponding form in this page (only visible to registered users) or contact us.

External resources for this compound

Bibliographic References

1 literature reference was collected for this gene.

If you have references for this compound, please enter them in a user comment (below) or Contact us.